CTA
ZTS icon

Chesley Taft & Associates’s Zoetis ZTS Stock Holding History

Chesley Taft & Associates’s Portfolio ZTS Stock Details ZTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
16,067
-17,131
-52% -$1.61M 0.05% 211
2026
Q1 		$3.92M Sell
33,198
-4,092
-11% -$506K 0.16% 106
2025
Q4 		$4.69M Sell
37,290
-2,574
-6% -$336K 0.19% 96
2025
Q3 		$5.83M Sell
39,864
-63,356
-61% -$9.58M 0.25% 83
2025
Q2 		$16.1M Sell
103,220
-3,324
-3% -$527K 0.72% 40
2025
Q1 		$17.5M Sell
106,544
-4,199
-4% -$698K 0.85% 38
2024
Q4 		$18M Sell
110,743
-260
-0.2% -$46.5K 0.84% 34
2024
Q3 		$21.7M Buy
111,003
+1,471
+1% +$271K 1.03% 30
2024
Q2 		$19M Buy
109,532
+49,473
+82% +$8.23M 0.95% 34
2024
Q1 		$10.2M Buy
60,059
+445
+0.7% +$83.4K 0.52% 53
2023
Q4 		$11.8M Buy
59,614
+27,745
+87% +$4.91M 0.66% 45
2023
Q3 		$5.54M Buy
31,869
+985
+3% +$179K 0.36% 69
2023
Q2 		$5.32M Buy
30,884
+8,000
+35% +$1.38M 0.33% 73
2023
Q1 		$3.81M Buy
22,884
+700
+3% +$115K 0.25% 88
2022
Q4 		$3.25M Sell
22,184
-472
-2% -$69.8K 0.22% 98
2022
Q3 		$3.36M Buy
22,656
+870
+4% +$145K 0.25% 92
2022
Q2 		$3.75M Sell
21,786
-337
-2% -$58.3K 0.26% 90
2022
Q1 		$4.16M Buy
22,123
+240
+1% +$47.4K 0.24% 88
2021
Q4 		$5.34M Buy
21,883
+430
+2% +$94.2K 0.28% 85
2021
Q3 		$4.17M Buy
21,453
+5
+0% +$1.01K 0.24% 93
2021
Q2 		$4M Sell
21,448
-954
-4% -$166K 0.23% 93
2021
Q1 		$3.55M Sell
22,402
-2,613
-10% -$414K 0.21% 95
2020
Q4 		$4.14M Buy
25,015
+160
+0.6% +$26K 0.26% 86
2020
Q3 		$4.11M Sell
24,855
-970
-4% -$149K 0.29% 80
2020
Q2 		$3.54M Buy
25,825
+600
+2% +$78.3K 0.27% 82
2020
Q1 		$2.97M Buy
25,225
+715
+3% +$94.1K 0.27% 81
2019
Q4 		$3.24M Sell
24,510
-45
-0.2% -$5.59K 0.23% 89
2019
Q3 		$3.06M Buy
24,555
+400
+2% +$48.3K 0.24% 88
2019
Q2 		$2.74M Buy
24,155
+200
+0.8% +$20.9K 0.21% 93
2019
Q1 		$2.41M Buy
23,955
+560
+2% +$50.8K 0.2% 96
2018
Q4 		$2M Sell
23,395
-375
-2% -$33.8K 0.19% 104
2018
Q3 		$2.18M Buy
23,770
+700
+3% +$62.1K 0.17% 112
2018
Q2 		$1.97M Buy
23,070
+1,015
+5% +$85.7K 0.17% 116
2018
Q1 		$1.84M Buy
22,055
+7,800
+55% +$614K 0.16% 120
2017
Q4 		$1.03M Buy
+14,255
New +$979K 0.09% 171

Other funds holding ZTS

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Chesley Taft & Associates's ZTS Position: Q2 2026 in Review

Chesley Taft & Associates reduced its Zoetis (ZTS) stake by 52% in Q2 2026, selling an estimated $1.61M and leaving 16,067 shares worth $1.15M. The position accounts for 0.05% of the portfolio, ranked #211.

Chesley Taft & Associates first reported a position in ZTS in Q4 2017 and has held it in 35 quarters since. The position peaked at $21.7M in Q3 2024. 265 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Chesley Taft & Associates held 16,067 shares of Zoetis worth $1.15M as of Q2 2026.
  • Chesley Taft & Associates sold 17,131 Zoetis shares in Q2 2026, an estimated $1.61M.
  • Zoetis made up 0.05% of Chesley Taft & Associates's portfolio in Q2 2026, its #211 holding.
  • Chesley Taft & Associates first reported a position in Zoetis in Q4 2017 and has held it in 35 quarters since.
  • Chesley Taft & Associates's Zoetis position peaked at $21.7M in Q3 2024.
  • 265 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.